These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29363174)

  • 21. Usefulness of TrichoScan professional in the evaluation of hair loss in females. Report of 180 cases.
    López V; Martín JM; Sánchez R; Ortega C; Ricart JM
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1068-72. PubMed ID: 21175874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Male androgenetic alopecia.
    Rathnayake D; Sinclair R
    Expert Opin Pharmacother; 2010 Jun; 11(8):1295-304. PubMed ID: 20426708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [What is the value of low-energie lasers in the treatment of androgenetic alopecia ?].
    Paquet P; Orduz M; Franchimont C; Nikkels AF
    Rev Med Liege; 2017 Dec; 72(12):540-546. PubMed ID: 29271134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trichoscopic findings in alopecia areata and their relation to disease activity, severity and clinical subtype in Turkish patients.
    Kibar M; Aktan Ş; Lebe B; Bilgin M
    Australas J Dermatol; 2015 Feb; 56(1):e1-6. PubMed ID: 23991834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods of hair loss evaluation: a comparison of TrichoScan(®) with the modified wash test.
    Guarrera M; Fiorucci MC; Rebora A
    Exp Dermatol; 2013 Jul; 22(7):482-4. PubMed ID: 23800060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Female androgenetic alopecia, a survey of causes and therapeutic options].
    Duchková H; Hašková M
    Cas Lek Cesk; 2015; 154(2):90-4. PubMed ID: 25994911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal triangular alopecia: significance of trichoscopy in differential diagnosis.
    Karadağ Köse Ö; Güleç AT
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1621-5. PubMed ID: 25187354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphological and morphometric study of the androgenetic alopecic scalp using two- and three-dimensional analysis comparing regional differences.
    Kim JN; Lee JY; Shin KJ; Gil YC; Koh KS; Song WC
    Br J Dermatol; 2014 Jun; 170(6):1313-8. PubMed ID: 24446778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent findings with computerized methods for scalp hair growth measurements.
    Hoffmann R; Van Neste D
    J Investig Dermatol Symp Proc; 2005 Dec; 10(3):285-8. PubMed ID: 16382682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems.
    Gentile P; Cole JP; Cole MA; Garcovich S; Bielli A; Scioli MG; Orlandi A; Insalaco C; Cervelli V
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methods of hair loss evaluation in patients with endocrine disorders].
    Olszewska M; Warszawik O; Rakowska A; Słowińska M; Rudnicka L
    Endokrynol Pol; 2011; 62 Suppl 1():29-34. PubMed ID: 22125108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hair morphology in androgenetic alopecia: sonographic and electron microscopic studies.
    Wortsman X; Guerrero R; Wortsman J
    J Ultrasound Med; 2014 Jul; 33(7):1265-72. PubMed ID: 24958413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Original article: Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation.
    Jha AK; Udayan UK; Roy PK; Amar AKJ; Chaudhary RKP
    J Cosmet Dermatol; 2018 Jun; 17(3):313-318. PubMed ID: 28771982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and molecular aspects of androgenetic alopecia.
    Martinez-Jacobo L; Villarreal-Villarreal CD; Ortiz-López R; Ocampo-Candiani J; Rojas-Martínez A
    Indian J Dermatol Venereol Leprol; 2018; 84(3):263-268. PubMed ID: 29595184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kenogen. A new phase of the hair cycle?
    Rebora A; Guarrera M
    Dermatology; 2002; 205(2):108-10. PubMed ID: 12218222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased scalp skin and serum 5 alpha-reductase reduced androgens in a man relevant to the acquired progressive kinky hair disorder and developing androgenetic alopecia.
    Boudou P; Reygagne P
    Arch Dermatol; 1997 Sep; 133(9):1129-33. PubMed ID: 9301590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trichoscopy for common hair loss diseases: algorithmic method for diagnosis.
    Inui S
    J Dermatol; 2011 Jan; 38(1):71-5. PubMed ID: 21175759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases.
    Miteva M; Misciali C; Fanti PA; Vincenzi C; Romanelli P; Tosti A
    Am J Dermatopathol; 2011 Jun; 33(4):345-50. PubMed ID: 21430504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hair loss: an overview.
    Mulinari-Brenner F; Bergfeld WF
    Dermatol Nurs; 2001 Aug; 13(4):269-72, 277-8. PubMed ID: 11917783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia.
    Watanabe Y; Nagashima T; Hanzawa N; Ishino A; Nakazawa Y; Ogo M; Iwabuchi T; Tajima M
    Int J Cosmet Sci; 2015 Dec; 37(6):579-87. PubMed ID: 25925959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.